Limbach Holdings, Inc. LMB 深 滬
已收盤 02-06 16:00:00 美东时间
86.13
+2.120
+2.52%
華盛通- 最 高89.39
- 今 開84.82
- 成交量 8.67万股
- 最 低 84.82
- 昨 收 84.01
- 總市值 10.01亿
- 52周最高 154.05
- 市盈率 靜 33.55
- 換手率 0.75%
- 52周最低 63.02
- 委 比 41.69%
- 總股本 1162.68万
- 歷史最高 154.05
- 量 比 0.52
- 振 幅 5.44%
- 歷史最低 2.37
- 每 手 1
- 風險率 23.64%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多美股大行评级 | 斯伦贝谢、SouthState Bank、西屋制动、特里科银行获多家大行上调目标价；苹果、meta、微软等绩前遭下调目标价
今日重点评级关注：Oppenheimer：维持Pelthos Therapeutics"跑赢大市"评级，目标价从57美元升至60美元；Small Cap Consumer Research：维持Lands' End"买入"评级，目标价从20美元升至45美元
01-27 10:02
Stifel Maintains Buy on Limbach Holdings, Lowers Price Target to $104
Stifel analyst Brian Brophy maintains Limbach Holdings (NASDAQ:LMB) with a Buy and lowers the price target from $111 to $104.
01-26 21:09
U.S. RESEARCH ROUNDUP-CACI International, First Citizens Bancshares, Teledyne Technologies
U.S. RESEARCH ROUNDUP-CACI International, First Citizens Bancshares, Teledyne Technologies Jan 26 (Reuters) - Wall Street securities analysts revised their ratings and price targets on several U.S.-listed companies, including CACI International, First Citizens Bancshares and Teledyne Technologies, o
01-26 15:22
美股大行评级 | 潜在涨幅263.64%！Milestone Pharmaceuticals获富国银行升目标价至8美元，维持"超配"评级
今日重点评级关注：富国银行：维持Milestone Pharmaceuticals"超配"评级，目标价从4美元升至8美元；富国银行：维持Kyverna Therapeutics"超配"评级，目标价从31美元升至33美元
2025-12-17 10:46
Stifel Maintains Buy on Limbach Holdings, Lowers Price Target to $111
Stifel analyst Brian Brophy maintains Limbach Holdings (NASDAQ:LMB) with a Buy and lowers the price target from $119 to $111.
2025-12-17 01:21
Limbach Announces $50M Share Repurchase Program Authorization
Limbach Holdings, Inc. (NASDAQ:LMB) ("Limbach" or the "Company"), a building systems solutions firm that partners with building owners and facilities managers who have mission-critical mechanical, electrical, and
2025-12-15 22:05
Limbach Holdings shares are trading lower. The company reported Q3 financial results.
Limbach Holdings shares are trading lower. The company reported Q3 financial re...
2025-11-05 22:13
Limbach Holdings Q3 Adj. EPS $1.05 Beats $0.85 Estimate, Sales $184.580M Beat $184.480M Estimate
Limbach Holdings (NASDAQ:LMB) reported quarterly earnings of $1.05 per share which beat the analyst consensus estimate of $0.85 by 23.53 percent. This is a 15.38 percent increase over earnings of $0.91 per share from the
2025-11-05 06:23
美股大行评级 | NTSK、STUB、WBI获多个机构首予评级；高盛上调雅诗兰黛(EL)评级至"买入"，目标价从76美元升至115美元
今日重点评级关注：花旗：维持Arcus Biosciences"买入"评级，目标价从47美元升至54美元；HC Wainwright & Co.：上调Karyopharm Therapeutics评级至"买入"，目标价15美元
2025-10-14 09:56
Stifel Maintains Buy on Limbach Holdings, Lowers Price Target to $132
Stifel analyst Brian Brophy maintains Limbach Holdings (NASDAQ:LMB) with a Buy and lowers the price target from $146 to $132.
2025-10-13 23:58
